Patents by Inventor Christian Chabbert

Christian Chabbert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210038682
    Abstract: The invention relates to a modulator of small conductance calcium activated K+ channels of the vestibular nuclei cells for use in the treatment of a lesional vestibular disorder in a patient in need thereof, and to a pharmaceutical composition comprising such modulator, for such a use.
    Type: Application
    Filed: March 13, 2019
    Publication date: February 11, 2021
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITE D'AIX-MARSEILLE (AMU)
    Inventors: Brahim Tighilet, Christian Chabbert, Christiane Mourre, David Pericat, Jacques LĂ©onard
  • Patent number: 10195195
    Abstract: The invention relates to Histamine H4 receptor antagonists or inhibitors of Histamine H4 receptor gene expression for the treatment and/or the prevention of vestibular disorders.
    Type: Grant
    Filed: November 8, 2016
    Date of Patent: February 5, 2019
    Assignee: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)
    Inventors: Gilles Desmadryl, Christian Chabbert
  • Publication number: 20170056397
    Abstract: The invention relates to Histamine H4 receptor antagonists or inhibitors of Histamine H4 receptor gene expression for the treatment and/or the prevention of vestibular disorders.
    Type: Application
    Filed: November 8, 2016
    Publication date: March 2, 2017
    Inventors: Gilles Desmadryl, Christian Chabbert
  • Patent number: 9526725
    Abstract: The invention relates to Histamine H4 receptor antagonists or inhibitors of Histamine H4 receptor gene expression for the treatment and/or the prevention of vestibular disorders.
    Type: Grant
    Filed: December 23, 2009
    Date of Patent: December 27, 2016
    Assignee: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)
    Inventors: Giles Desmadryl, Christian Chabbert
  • Patent number: 8580730
    Abstract: The invention relates to serotonin 5-HT3 receptor antagonists or inhibitors of serotonin 5-HT3 receptor gene expression for use in the treatment of a lesional vestibular disorder.
    Type: Grant
    Filed: May 20, 2010
    Date of Patent: November 12, 2013
    Assignee: (INSERM) Institut National de la Sante et de la Recherche Medicale
    Inventors: Christian Chabbert, Frederic Venail
  • Publication number: 20120064094
    Abstract: The invention relates to serotonin 5-HT3 receptor antagonists or inhibitors of serotonin 5-HT3 receptor gene expression for use in the treatment of a lesional vestibular disorder.
    Type: Application
    Filed: May 20, 2010
    Publication date: March 15, 2012
    Applicant: INSERM (Institut National de la Sante et de la Recherche Medicale)
    Inventors: Christian Chabbert, Frederic Venail
  • Publication number: 20120039913
    Abstract: The invention relates to Histamine H4 receptor antagonists or inhibitors of Histamine H4 receptor gene expression for the treatment and/or the prevention of vestibular disorders.
    Type: Application
    Filed: December 23, 2009
    Publication date: February 16, 2012
    Applicant: INSERM (institut National de la Sante de la Recher Medicale)
    Inventors: Gilles Desmadryl, Christian Chabbert